Ayurvedic management of Diabetic Nephropathy (stage 1 and 2)
Phase 2
- Conditions
- Health Condition 1: E132- Other specified diabetes mellituswith kidney complicationsHealth Condition 2: E112- Type 2 diabetes mellitus with kidney complicationsHealth Condition 3: E112- Type 2 diabetes mellitus with kidney complications
- Registration Number
- CTRI/2022/09/045629
- Lead Sponsor
- All India Institue Of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diabetic patients having controlled blood glucose level upto
FBS:130mg/dl
PPBS:180mg/dl. (American Diabetes Association)
c) Hypertensive patients BP < 140/90 mm of Hg
d) Urinary albumin between 30-300mg in 24 Hr. urine sample
e) G.F.R. between 60-120ml/min/1.73m2
Exclusion Criteria
Uncontrolled diabetic patients if blood glucose level more than-
FBS: 130 mg/dl
PPBS:180 mg/dl
b) Uncontrolled Hypertensive patients BP �140/90 mm of Hg.
c) Microalbuminuria originating due to other diseases
d) Patients with other severe complications of Diabetes Mellitus.
e) Serum creatinine more than 2.5 mg.
f) Albumin >300mg/day.
g) G.F.R. <60 ml/min.
h) Any other serious systemic illness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate efficacy of selective Ayurvedic formulations on progression of diabetic kidney disease in 30 days <br/ ><br>disease. <br/ ><br>Timepoint: 30 days <br/ ><br>
- Secondary Outcome Measures
Name Time Method To evaluate the Glomerular filtration Rate (eGFR) and Renal functionsTimepoint: 30 days